Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Capital Employed (2020 - 2023)

Historic Return on Capital Employed for ADC Therapeutics (ADCT) over the last 4 years, with Q3 2023 value amounting to 19.09%.

  • ADC Therapeutics' Return on Capital Employed rose 1243300.0% to 19.09% in Q3 2023 from the same period last year, while for Sep 2023 it was 19.09%, marking a year-over-year increase of 1243300.0%. This contributed to the annual value of 0.0% for FY2022, which is N/A changed from last year.
  • As of Q3 2023, ADC Therapeutics' Return on Capital Employed stood at 19.09%, which was up 1243300.0% from 19.1% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Capital Employed registered a high of 0.09% during Q3 2020, and its lowest value of 143.42% during Q3 2022.
  • Its 4-year average for Return on Capital Employed is 51.78%, with a median of 22.19% in 2022.
  • Per our database at Business Quant, ADC Therapeutics' Return on Capital Employed plummeted by -1430100bps in 2022 and then skyrocketed by 1243300bps in 2023.
  • Over the past 4 years, ADC Therapeutics' Return on Capital Employed (Quarter) stood at 0.09% in 2020, then crashed by -137603bps to 119.0% in 2021, then surged by 79bps to 25.27% in 2022, then increased by 24bps to 19.09% in 2023.
  • Its Return on Capital Employed stands at 19.09% for Q3 2023, versus 19.1% for Q2 2023 and 27.28% for Q1 2023.